文献速递先天性心脏病外科

重新审视法洛四联症根治术后技术表现评分的效用

Revisiting the utility of technical performance scores following tetralogy of Fallot repair.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-04-05

该回顾性单中心研究纳入2007至2015年115例2岁以下法洛四联症根治术患儿,评估现行技术表现评分与术后结局的关系。

要点

  • 现行技术表现评分与术后住院时间、并发症及费用无显著关联
  • 体外循环时间延长和再次转机是影响结局的重要因素
  • 建议未来修订评分时纳入体外循环时间和再次转机变量

核心结论

  • 现行法洛四联症技术表现评分在本术后人群中与所选结局无关。
  • 再次转机和体外循环时间未纳入现行评分,但为影响并发症和资源使用的重要因素。

研究设计与样本

  • 回顾性单中心研究,纳入2007至2015年115例2岁以下接受法洛四联症完全根治术的患者。
  • 通过病历数据和出院超声心动图确定技术表现评分的组成和综合评分。
  • 主要结局为术后住院时间、主要并发症和总住院费用,采用多因素logistic和线性回归分析 determinants。

主要发现

  • 患者术后住院时间中位数8天(四分位距6-10天),总费用中位数71,147美元。
  • 33例(29%)发生主要并发症,1例死亡。
  • 技术表现评分:最佳28例(25%),充分59例(52%),不充分26例(23%)。
  • 评分组成或综合评分均与术后住院时间延长无关。

临床怎么用

  • 现行技术表现评分可能不足以全面评估法洛四联症根治术后结局。
  • 临床应关注体外循环时间和再次转机等手术因素对资源使用和并发症的影响。

局限性

  • 回顾性单中心研究,样本量115例,结果外推需谨慎。
  • 未纳入前瞻性验证,结论需进一步研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although an important quality metric, current technical performance scores may not be generalizable and may omit operative factors that influence outcomes. We examined factors not included in current technical performance scores that may contribute to increased postoperative length of stay, major complications, and cost after primary repair of tetralogy of Fallot. METHODS: This is a retrospective single site study of patients younger than age 2 years with tetralogy of Fallot undergoing complete repair between 2007 and 2015. Medical record data and discharge echocardiograms were reviewed to ascertain component and composite technical performance scores. Primary outcomes included postoperative length of stay, major complications, and total hospital costs. Multivariable logistic and linear regression identified determinants of each outcome. RESULTS: Patient population (n = 115) had a median postoperative length of stay of 8 days (interquartile range, 6-10 days), and a median total cost of $71,147. Major complications occurred in 33 patients (29%) with 1 death. Technical performance scores assigned were optimum in 28 patients (25%), adequate in 59 patients (52%), and inadequate in 26 patients (23%). Neither technical performance score components nor composite scores were associated with increased postoperative length of stay. Optimum or adequate repairs versus inadequate had equal risk of a complication (P = .79), and equivalent mean total cost ($100,000 vs $187,000; P = .25). Longer cardiopulmonary bypass time per 1-minute increase (P < .01) was associated with longer postoperative length of stay and reintervention (P = .02). The need to return to bypass also increased total cost (P < .01). CONCLUSIONS: Current tetralogy of Fallot technical performance scores were not associated with selected outcomes in our postoperative population. Although returning to bypass and bypass length are not included as components in the current score, these are important factors influencing complications and resource use in our population. Revisions anticipated from a prospective trial should consider including these variables.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Lodin D, Mavrothalassitis O, Haberer K, et al. Revisiting the utility of technical performance scores following tetralogy of Fallot repair. J Thorac Cardiovasc Surg. 2017. PMID: 28461051. doi:10.1016/j.jtcvs.2017.02.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。